Institutional investors purchased a net $1.1 million shares of ENZ during the quarter ended October 2014. This may signal that the smart money is gaining interest in this company as the 44.96% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 2.1 Million shares of Enzo Biochem Inc
BLUE CLAY CAPITAL MANAGEMENT LLC Bought 186.9 Thousand shares of Enzo Biochem Inc
BLACKROCK FUND ADVISORS Bought 180.6 Thousand shares of Enzo Biochem Inc